Acquired
Novo Nordisk (Ozempic)
Ben Gilbert
And it is worth pointing out when I say the expensive one, 29% of all R&D for a drug is spent right here. So phase one is 9%, phase two is 12%, phase three is 29% with the rest of it sort of coming from that early basic research, drug discovery, preclinical studies, and a little bit later with the regulatory review.
0
💬
0
Comments
Log in to comment.
There are no comments yet.